RocRock Biotechnology
PrivateLast Round
Series A
Nov 20, 2025
Total Funding Raised
$6.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RocRock Biotechnology operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series A round in November 2025.
RocRock Biotechnology is a biotechnology company that develops engineered macrophage technology and macrophage-based drug therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RocRock Biotechnology Comparables
Compare RocRock Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellOrigin Biotech | 88% | |
| Carisma Therapeutics | 81% | |
| Thunder Biotech | 81% |
For institutional investors. Book with your work email.
RocRock Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 20, 2025 | ||||
| Angel | Oct 1, 2022 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
$7M round completed.
- Oct 1, 2022
Completed an angel funding round.
For institutional investors. Book with your work email.
RocRock Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RocRock Biotechnology's valuation, stock price, and market status.
Is RocRock Biotechnology a public or private company?
RocRock Biotechnology is a private company.
What is the current stock price of RocRock Biotechnology?
RocRock Biotechnology is a private company, so its shares have no public market price. Caplight tracks RocRock Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RocRock Biotechnology worth (valuation)?
Valuation information for RocRock Biotechnology is not publicly available.
Can I buy RocRock Biotechnology stock?
RocRock Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RocRock Biotechnology's last funding round?
RocRock Biotechnology's most recent funding round was Series A on November 20, 2025.
Who are the main investors in RocRock Biotechnology?
Investor information for RocRock Biotechnology is not publicly disclosed.
Will RocRock Biotechnology IPO soon?
No public IPO plans have been announced for RocRock Biotechnology.
How can I track RocRock Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in RocRock Biotechnology's shares on secondary markets.